Acute effects of moclobemide and deprenyl on 5-HT synthesis rates in the rat brain: An autoradiographic study

Brain Research Bulletin

Volumn 70, Issue 4-6, 2006, Pages 368-377

  Nishi, Kyoko ^a   Mück Šeler, Dorotea ^a   Hasegawa, Shu ^a   Watanabe, Arata ^a   Diksic, Mirko ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Methyltryptophan; Autoradiography; Deprenyl; Moclobemide; Rat brain regions; Serotonin (5 HT); Synthesis rate

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; AUTORECEPTOR; CARBON 14; MOCLOBEMIDE; N METHYLTRYPTOPHAN; SELEGILINE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN; CATECHOLAMINE NERVE CELL; CINGULATE GYRUS; CONTROLLED STUDY; HORMONE SYNTHESIS; LOCUS CERULEUS; MALE; NERVE ENDING; NONHUMAN; PRIORITY JOURNAL; RAPHE NUCLEUS; RAT; SEROTONINERGIC NERVE CELL;

ANIMALS; AUTORADIOGRAPHY; BRAIN; CARBON ISOTOPES; MALE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; SELEGILINE; SEROTONIN; TRYPTOPHAN;

EID: 33749268199     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2006.06.011     Document Type: Article

References (64)

1. Blackburn K.J., French P.C., and Merrills R.J. 5-Hydroxytryptamine uptake by rat brain in vitro. Life Sci. 6 (1967) 1653-1663
2. Bloxam D.L., and Curzon G. A study of proposed determinants of brain tryptophan concentration in rats after portocaval anastomosis or sham operation. J. Neurochem. 31 (1978) 255-1263
3. Bonnet U. Moclobemide: evolution, pharmacodynamic, and pharmacokinetic properties. CNS Drug Rev. 8 (2002) 283-308
4. Carlsson A., Kehr W., and Lindqvist M. The role of intraneuronal amine levels in the feedback control of dopamine, noradrenaline and 5-hydroxytryptamine synthesis in rat brain. J. Neural Transm. 39 (1976) 1-19
5. Casacchia M., Carolei A., Barba C., Frontoni M., Rossi A., Meco G., and Zylberman M.R. A placebo-controlled study of the antidepressant activity of moclobemide, a new MAO-A inhibitor. Pharmacopsychiatry 17 4 (1984) 122-125
6. Celada P., and Artigas F. Monoamine oxidase inhibitors increase preferentially extracellular 5-hydroxytryptamine in the midbrain raphe nuclei. A brain microdialysis study in the awake rat. Naunyn-Schmiedebergs Arch. Pharmacol. 347 (1993) 583-590
7. Da Prada M., Kettler R., Keller H.H., Burkard W.P., Muggli-Maniglio D., and Haefely W.E. Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A. J. Pharmacol. Exp. Ther. 248 (1989) 400-414
8. +-dependent, fluoxetine-sensitive serotonin uptake by astrocytes tissue-printed from rat cerebral cortex. J. Neurosci. 14 (1994) 4972-4986
9. De la Cruz C.P., Revilla E., Steffen V., Rodriguez-Gomez J.A., Cano J., and Machado A. Protection of the aged substantia nigra of the rat against oxidative damage by (-)-deprenyl. Br. J. Pharmacol. 117 (1996) 1756-1760 (Journal Article)
10. Demarest K.T., Smith D.J., and Azzaro A.J. The presence of the type A form of monoamine oxidase within nigrostriatal dopamine-containing neurons. J. Pharmacol. Exp. Ther. 215 2 (1980) 461-468
11. Denney R.M., and Denney C.B. An update on the identity crisis of monoamine oxidase: new and old evidence for the independence of MAO A and B. Pharmacol. Ther. 30 3 (1985) 227-258
12. Diksic M., Nagahiro S., Chaly T., Sourkes T.L., Yamamoto Y.L., and Feidel W. Serotonin synthesis rate measured in living dog brain by positron emission tomography. J. Neurochem. 56 (1991) 153-162
13. Diksic M., Nagahiro S., Sourkes T.L., and Yamamoto Y.L. A new method to measure brain serotonin synthesis in vivo. I. Theory and basic data for a biological model. Cerebr. Blood Flow Metab. 10 (1990) 1-12
14. Dobson C.F., Tohyama Y., Diksic M., and Hamel E. Effects of acute or chronic administration of anti-migraine drugs sumatriptan and zolmitriptan on serotonin synthesis in the rat brain. Cephalalgia 24 (2004) 2-11
15. Dostert P.L., Strolin K.F., Benedetti M., and Tipton K.F. Interactions of monoamine oxidase with substrate and inhibitors. Med. Res. Rev. 9 (1989) 45-89
16. Fagerval I., and Ross S.B. A and B forms of monoamine oxidase within the monoaminergic neurons of the rat brain. J. Neurochem. 47 (1986) 569-576
17. Felner A.E., and Waldmeir P.C. Cumulative effects of irreversible MAO inhibitors in vivo. Biochem. Pharmacol. 28 (1979) 995-1002
18. Ferre S., and Artigas F. Dopamine D2 receptor-mediated regulation of serotonin extracellular concentration in the dorsal raphe nucleus of freely moving rats. J. Neurochem. 61 (1993) 772-775
19. Fitzegerald L.W., Kaplinsky L., and Kimelberg H.K. Serotonin metabolism by monoamine oxidase in rat primary astrocyte cultures. J. Neurochem. 55 (1990) 2008-2014
20. Fulton P., and Benfield B. Moclobemide: an update of its pharmacological properties and therapeutic use. Drugs 52 (1996) 450-474 (erratum appears in Drugs 52(6):869)
21. Garrick N.A., and Murphy D.L. Monoamine oxidase type A: differences in selectivity towards l-norepinephrine compared to serotonin. Biochem. Pharmacol. 31 24 (1982) 4061-4066
22. Gerlach M., Youdim M.B.H., and Riederer P. Pharmacology of selegiline. Neurology 47 Suppl. 3 (1996) S137-S145
23. Hasegawa S., Watanabe A., Nguyen K.Q., Debonnel G., and Diksic M. Chronic administration of citalopram in olfactory bulbectomy rats restores brain 5-HT synthesis rates: an autoradiographic study. Psychopharmacology 179 (2005) 781-790
24. 1B receptor agonist reduces serotonin synthesis following acute, and not chronic, drug administration: results of an autoradiographic study. Neurochem. Int. 46 (2005) 261-272
25. Higuchi H., Kamata M., Sugawara Y., and Yoshida K. Remarkable effect of selegiline (l-deprenyl), a selective monoamine oxidase type-B inhibitor, in a patient with severe refractory depression: a case report. Clin. Neuropharmacol. 28 (2005) 191-192
26. Jacobs B.L., and Azmitia E.C. Structure and function of the brain serotonin system. Physiol. Rev. 72 (1992) 165-229
27. Kalen P., Skagerberg G., and Lindvall O. Projections from ventral tegmental area and mesencephalic raphe to the DRN in the rat. Exp. Brain Res. 73 (1988) 69-77
28. Knoll J. The striatal dopamine dependency of life span in male rats. Longevity study with (-)-deprenyl. Mech. Ageing Dev. 46 (1988) 237-262
29. 14C clorgyline autoradiography. Exp. Brain Res. 99 (1994) 375-382
30. Kumagae Y., Matsui Y., and Iwata N. Deamination of norepinephrine, dopamine and serotonin by type A monoamine oxidase in discrete regions of the rat brain and inhibition by RS-8359. Jpn. J. Pharmacol. 55 (1991) 121-128
31. Mann J.J., Aarons S.F., Wilner P.J., Keilp J.G., Sweeney J.A., Pearlstein T., Frances A.J., Kocsis J.H., and Brown R.P. A controlled study of the antidepressant efficacy and side effects of (-)-deprenyl. A selective monoamine oxidase inhibitor. Arch. Gen. Psychiatr. 46 (1989) 45-50
32. Muck-Seler D., Jevric-Causevic A., and Diksic M. Influence of fluoxetine on regional serotonin synthesis in the rat brain. J. Neurochem. 67 (1996) 2434-2442
33. Muller D.J., Schulze T.G., Macciardi F., Ohlraun S., Gross M.M., Scherk H., Neidt H., Syagailo Y.V., Grassle M., Nothen M.M., Maier W., Lesch K.P., and Rietschel M. Moclobemide response in depressed patients: association study with a functional polymorphism in the monoamine oxidase A promoter. Pharmacopsychiatry 35 (2002) 157-158
34. Nagahiro S., Takada A., Diksic M., Sourkes T.L., Missala K., and Yamamoto Y.L. A new method to measure brain serotonin synthesis in vivo. II. A practical autoradiographic method tested in normal and lithium-treated rats. J. Cerebr. Blood Flow Metab. 10 (1990) 13-21
35. Naoi M., Maruyama W., Takahashi T., Ota M., and Parvez H. Inhibition of tryptophan hydroxylase by dopamine and the precursor amino acids. Biochem. Pharmacol. 48 (1994) 207-221
36. Nelson N. Presynaptic events involved in neurotransmission. J. Physiol. (Paris) 87 (1993) 171-178
37. Nishizawa S., Benkelfat C., Young S.N., Leyton M., Mzengeza S., De Montigny C., Blier P., and Diksic M. Differences between males and females in rates of serotonin synthesis in human brain. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 5308-5313
38. 1A agonist buspirone on serotonin synthesis in the rat brain. J. Neurochem. 72 (1999) 2022-2031
39. Oreland L., Arai Y., Stenstrom A., and Fowler C.J. Monoamine oxidase activity and localisation in the brain and the activity in relation to psychiatric disorders. Mod. Probl. Pharmacopsychiatr. 19 (1983) 246-254
40. Oreland L., and Engberg G. Relation between brain monoamine oxidase (MAO) activity and the firing rate of locus coeruleus neurons. Naunyn-Schmiedebergs Arch. Pharmacol. 333 (1986) 235-239
41. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1986), Academic Press, New York
42. Pineyro G., and Blier P. Autoregulation of serotonin neurons: role in antidepressant drug action. Pharmacol. Rev. 51 (1999) 533-591
43. Rodriguez-Gomez J.A., Venero J.L., Vizuete M.L., Cano J., and Machado A. Deprenyl induces the tyrosine hydroxylase enzyme in the rat dopaminergic nigrostriatal system. Brain Res. Mol. Brain Res. 46 (1997) 31-38
44. Sakai K., Touret M., Salvert D., Leger L., and Jouvet M. Afferent projections to the cat locus coeruleus as visualized by the horseradish peroxidase technique. Brain Res. 119 (1977) 21-41
45. Salter M., Knowles R.G., and Aogson C.L. How dose displacement of albumin-bound tryptophan cause sustained increases in the free tryptophan concentration in plasma and 5-hydroxytryptamine synthesis in the brain?. Biochem. J. 262 (1989) 365-368
46. Sano M., Ernesto C., Thomas R.G., Klauber M.R., Schafer K., Grundman M., Woodbury P., Growdon J., Cotman C.W., Pfeiffer E., Schneider L.S., and Thal L.J. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease: The Alzheimer's Disease Cooperative Study. N. Engl. J. Med. 336 (1997) 1216-1222
47. 3H-Ro 19-6327 in vitro: localization and abundance of MAO-A and MAO-B in rat CNS, peripheral organs and human brain. J. Neurosci. 12 (1992) 1977-1999
48. Shih J.C. Molecular basis of human MAO-A and -B. Neuropsychopharmacology 4 (1991) 1-7
49. Shih J.C., and Thompson R.F. Monoamine oxidase in neuropsychiatry and behavior. Am. J. Hum. Genet. 65 (1999) 593-598
50. Stassen H.H., Angst J., and Delini-Stula A. Fluoxetine versus moclobemide: cross-comparison between the time courses of improvement. Pharmacopsychiatry 32 2 (1999) 56-60
51. Stenfors C., and Ross S.B. Evidence for involement of protein kinases in the regulation of serotonin synthesis and turnover in the mouse brain in vivo. J. Neural Transm. 109 (2002) 1353-1363
52. Strolin Benedetti M., Boucher T., and Fowler C.J. The deamination of noradrenaline and 5-hydroxytryptamine by rat brain and heart monoamine oxidase and their inhibition by cimoxatone, toloxatone and MD 770222. Naunyn-Schmiedebergs Arch. Pharmacol. 323 (1983) 315-320
53. Takada A., Grdiša M., Diksic M., Gjede A., and Yamamoto L.Y. Rapid steady-state analysis of blood-brain transfer of L-Trp in rat, with special reference to the plasma protein binding. Neurochem. Int. 23 (1993) 351-359
54. Takagi H., and Segawa T. Serotonin. In: Yamasaki H., and Yoshida H. (Eds). Seitaiamin (Biogenig Amines) (1975), Ishiyaku Publishers Inc., Tokyo 213-255
55. 2-Adrenoceptor modulation of rat ventral hippocampal 5-hydroxytryptamine release in vivo. Naunyn-Schmiedebergs Arch. Pharmacol. 345 (1992) 137-143
56. ThyagaRajan S., and Quadri S.K. l-Deprenyl stimulates the release of catecholamines in the rat medial basal hypothalamus in vivo. Neurosci. Lett. 270 (1999) 79-82
57. ThyagaRajan S., Madden K.S., Stevens S.Y., and Felten D.L. Effects of l-deprenyl treatment on noradrenergic innervation and immune reactivity in lymphoid organs of young F344 rats. J. Neuroimmunol. 96 1 (1999) 57-65
58. 14C]methyl-l-tryptophan. Eur. Neuropsychopharmacol. 11 (2001) 193-202
59. Tohyama Y., Yamane F., Fikre-Merid M., Blier P., and Diksic M. Effects of serotonin receptor agonists, TFMP and CGS12066B, on regional serotonin synthesis in the rat brain: an autoradiographic study. J. Neurochem. 80 (2002) 788-798
60. Vanier M., Tsuiki K., Grdiša M., Worsley K., and Diksic M. Determination of the lumped constant for the α-methyltryptophan method of estimating the rate of serotonin synthesis. J. Neurochem. 64 (1995) 624-635
61. Waldmeier P.C. Effects of chronic antidepressant treatment on pre- and post-synaptic dopaminergic mechanisms: a short review of the literature and some complementary experiments. Pol. J. Pharmacol. Pharm. 36 (1984) 201-216
62. 14C]methyl-l-tryptophan. Biochem. Pharmacol. 62 (2001) 1481-1489
63. Yang H.Y., and Neff N.H. The monoamine oxidases of brain: selective inhibition with drugs and the consequences for the metabolism of the biogenic amines. J. Pharmacol. Exp. Ther. 189 3 (1974) 733-740
64. 2-Adrenoceptor modulation of 5-HT biosynthesis in the rat brain. Neurosci. Lett. 139 (1992) 53-56